AAAAAA

   
Results: 1-23 |
Results: 23
HIGHER LEVELS OF ACTIVATED FACTOR-VII MAY BE ASSOCIATED WITH SUBSEQUENT DEATH
Authors: EICHNER JE SCHECHTER E MOORE WE MOBLEY BA MORRISSEY JH COMP PC
Citation: Je. Eichner et al., HIGHER LEVELS OF ACTIVATED FACTOR-VII MAY BE ASSOCIATED WITH SUBSEQUENT DEATH, Circulation, 98(17), 1998, pp. 2381-2381
THE CLINICAL VALIDITY OF NORMAL COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF RAVING DEEP VENOUS THROMBOSIS
Authors: BIRDWELL BG RASKOB GE WHITSETT TL DURICA SS COMP PC GEORGE JN TYTLE TL MCKEE PA
Citation: Bg. Birdwell et al., THE CLINICAL VALIDITY OF NORMAL COMPRESSION ULTRASONOGRAPHY IN OUTPATIENTS SUSPECTED OF RAVING DEEP VENOUS THROMBOSIS, Annals of internal medicine, 128(1), 1998, pp. 1
THROMBOPHILIC MECHANISMS OF OCS
Authors: COMP PC
Citation: Pc. Comp, THROMBOPHILIC MECHANISMS OF OCS, International journal of fertility and women's medicine, 42, 1997, pp. 170-176
EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN (ARDEPARIN SODIUM) COMPARED TO WARFARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT SURGERY - A DOUBLE-BLIND DOSE-RANGING STUDY
Authors: HEIT JA BERKOWITZ SD BONA R CABANAS V CORSON JD ELLIOTT CG LYONS R BALLARD WP HENDERSON C COLWELL CW COMP PC EKLOF B FRIEDMAN R GOBLE M GREEN D HAIRE W HYERS T OHAR J INCAVO S KESSLER C LOTKE P MOORE DE PINZUR MS GODWIN J SACK M SCOTT WN STERLING R GOUAUX J STEWART J SUCHYTA M TROWBRIDGE A WENGLER MK WINTERS T ZAOUTIS LB HOLLOWAY DS DILIBERTO JM ROSSI MJ
Citation: Ja. Heit et al., EFFICACY AND SAFETY OF LOW-MOLECULAR-WEIGHT HEPARIN (ARDEPARIN SODIUM) COMPARED TO WARFARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT SURGERY - A DOUBLE-BLIND DOSE-RANGING STUDY, Thrombosis and haemostasis, 77(1), 1997, pp. 32-38
RANDOMIZED DOUBLE-BLIND TRIAL OF FIXED LOW-DOSE WARFARIN WITH ASPIRINAFTER MYOCARDIAL-INFARCTION
Authors: FUSTER V CALIFF RM CHESEBRO JH COHEN M COMP PC GHEORGHIADE M HALL J HALPERIN J KHAN S KOPECKY S LANGER A MOLK B MOSS A OCONNOR CM OGARA PT RASKOB E SUTTON J BRAUNWALD E BELL WR FURBERG C RAPAPORT E DEMETS D GOLDSTEIN S RICHARDSON D HILLIS D BONOW R KISTLER JP MOHR JP SHERMAN D FISHER M FEYZI J COOK T CALIFF RM HARRINGTON RA BERKOWITZ SD JETT L BERDAN L MCDOUGAL M FRIEDMAN E DANIEL J RONCSKEVITZ E HWANG S CROWELL D PAGANINI M ANDAHL L OCONNOR C LUCAS K COLLINS GJ MARK RJ SIEGEL RM KOEHNEMANN G GREER S SCHWEITZER AC LAWRENCE JE ALLEN SM WISEMAN AH WARWICK DJ BENNETT WT SIMMONS K SHEIKH KH HENGERER T CAMPBELL PT PATTERSON JT BATES M MATHEWS A ROARK SF MARQUIS N GOLDNER DB BROWN G PARKER JP WELLS CB MCGREW FA HAMILTON B CARNEY RJ CRISPIN S CUMMINS FE NONNWEILER JM COLLINS GV HATHAWAY J CONN E MCWILLIAMS C GEROGE JM RONCEVICH T REEVES BR DINSMORE N BENDER R DEROSA K OCONNOR CM HOFFMAN S WERTHEIMER J TURNER S CRANDALL CW HIGGINS DL BERGER BC PALAZZO D FONTANET H FORD E CHU AA PIERSON M SEAWORTH JF JENSEN J HOCHE JP FORD EA GOODFIELD P SPROWLS H SCHMIDT PJ NESS C ODONNELL G MCNAMEE S KOREN MJ BAKER J HASSEL CD HARTLEY D UNKS M RODGERS K MUHLESTEIN JB ALLEN A SACCHI TJ MAJOR A KMONICEK JM SHANE JW GOULAH RD HARNER R BANNON PJ HEYL AE WALL TC MILKS S RAMO BW HEIMGARTNER K VRANIAN RB LOUDER DR STACK RK JACKSON LL BERMAN EJ HAWKINS D AYCOCK GR WILCOX T WEST SR FOWLER P ALAGONA P MOORE A HINES J MINOR JR KEREIAKES DJ MARTIN LH FRID DJ HOMAN JA BURKS JM KIRBY JC PUMA J JONES L SCHNEIDER RM LYTTLE B TALLEY JD ASHCRAFT S JOSEPH A CORUMHARTLY J MCNEER JF LADEN DL BELKIN RN WILLIAMSON J LANGER A HILL C BUTTOO K KACHRA A LANGER G KAVANNAUGH L SHRIVES DM STRAUSS H ANDERSON P KWOK K KERN C CHEUNG MT NAWROCKI H DARCEL IC ALI N CAMPBELL D SLUZAR V HINK H LAM J MARQUIS J PARKER JD WILSON J JAMES R NOLF B ZAWADOWSKI A BHARGAVA R GUPTA M SEVITT B FITZSIMONS J BURKE BR CHOMYC R SINGH N BOZEK B ROTH SL SMITH J FELL DA WILLOUGHY L RANGANATHAN N NAWROCKI H LANGER A HILL C MORGAN C BALLEZA L SASSON Z NOLF B LENKEIKERWIN S WILSON J MCALISTER NH KARHRA N GANGBAR E WILLOUGHBY L HESS A GAUDET M BHESANIA T BURGE D OGARA P HAGGAN C GIBSON M SLATER A STONE PH CLEMENTE C POLANSKY BJ CLEMENTS PJ SCHAEL F MCGOUGH E DAUM RM CAREY G GILLAM LD HALL DJ VENDITTI FJ WOODHEAD G BIRKHEAD RG MCCONNELL D JANG IK HAGGAN C SADANIANTZ A STAPLES E WEINSHEL AJ WEINSHEL G COHEN M SHERWOOD J PALABRICA T BROWN AM HACK TC PAVAO F MCKENDALL FR WHEELER JL GAUGHAN C MEDICI SE LOSORDO DW HALLETTE N WALDMAN H CRIASIA M BATTLE R ROWEN M KLEIN ME HANKIN B RADFORD MJ KEARNEY L BECKER RC BALL SP SHARMA GVRK LAPSLEY DP WATROUS BG STANTON A KOPECKY S HOLLAND A SHELHAMER L GUDMONSON K BASU HN BRICKMAN D RAMEE SR LANDRY KJ HELTNE CE BERGAL LA LYONS RM BUSSEY HI ASINGER R FIFIELD JH BRUNS DL GADIENT L KINCAID D BERG S STORVICK E WESTPHAL D REZKALLA SH WHITE E SAFFORD RE DOUCETTE K COOKMAN JJ FANGMAN L ANDERSON BJ SWAN M KOUBA C THEIGE T VACEK JL NOLTE B HURLEY DV KASKIE K GARD JR HARRE SJ SOLBERG L MILLER K MILLER RR RICKARDS J YAWN RA KURLAND M HAUGLAND JM SLIVKEN R HESSION WT STRUM S STOWERS SA ABUAN T DEWOOD MA REINHARDT S KOPECKY SL RICHARDSON D ISELE R BLOCK C SWENSON LJ VITTUM KA WEEKS G BRENNAN M CHAPMAN D THOMMORGAN J CHELLIAH N CARTER D FRIEDMAN B HAFFEY K WEBEL R ROOD M ANDREWS TC JULY ME EDIN AE HESTER TS SUTTON J MCCOLLOUGH T SCHULMAN D DELOPLAINE K BESLEY D DUNN S RICHARDS F SHIPMAN D JOSEPHSON RA JASSO D FLEISCHER L LOFRANO S SPRIGGS D WAHL S FONT VE TROTTIER M SUTTON J DELUCA SA SCHWARZ EF BECKHAM T MICKOLICH JR SNYDER M LANGHOLZ D JOHNSON E BEAVER BB TEDRICK R BOYD JJ PROBST P BEAR PA CRAIG MB BLUMENTHAL RS CARNES T VILLA AE ATKINS F STORER WQ PAYNE MA ODONNELL MJ PROCHNOW L YAKUBOV S NOETHEN A GONZALEZ M JOPPERI E JOYCE D MISHAK S REEN BM WHISNANT DR GACIOCH GM CHIODO V EFFRON MB UTLEY K FRANK S DANKOSKI C KRAUTHAMER D WELCOM GT AGUIRRE FV STONNER T CANNON L HARRIS M BROWN DL MOEHUFFORD K HATTEMER CR HOWARD W GILMORE PS WOFFORD R BATES ER ALEXANDRIS C MCCLURE JM DINNINGER J MOLK B DANHOUR G PACHECO JP LONGO JA MOLK BL BICKETT K BAUM RS JENKINS R BROCKINGTON L HARDING C LUCKASEN GJ RAYDER K PTASNIK MJ HARDING C BRACHFELD CA VINCZE T CADIGAN RA WUBBENA BA SMITH BR ONEILL D PACHELO GM GODFREY CC FECIK C LARSON D RAYDER K BACKUP LD DRAKE Z MIKLIN JS ARIS G SCHWARTZ DJ STARK S SMITH S EASTBURN T MARSH R LORENZ S THOMPSON R KLEINMAN J ARIS G BRECKINRIDGE JC DAUBER IM BELL W VANBENTHUYSEN K PREVEDEL J FECIK C STRINGER KA WHITEROCK A LEVITT PW PETRAS J COHEN M STOAKES K DANIELS S STERNBERG C MAZUZ M FRYMOYER BS DICKSTEIN RA BANGER D KRAMER JH EVANS C VICTOR M LUHMANN S WORLEY WJ TUZI J JANZER SF LYSGAARD JK STILLABOWER ME DISABATINO A VOYCE S KEATING D COHEN M STOAKES K ZAKRZEWSKI M HAYES C OWENS JS AMBURG C ZATUCHNI J BOYLE M GHEORGHIADE M MISTOVICH M ZAYAC J DEGIROLAMI D PETERSON D GLICK G REDA A HUETER D WESZT S WYNNE J LADD DF MATHEW J DAVIDSON S BORZAK S CRUZ TA CHIU C SEDLARZ P SHANES JG CALKINS M ALEXANDER J
Citation: V. Fuster et al., RANDOMIZED DOUBLE-BLIND TRIAL OF FIXED LOW-DOSE WARFARIN WITH ASPIRINAFTER MYOCARDIAL-INFARCTION, Lancet, 350(9075), 1997, pp. 389-396
ACTIVATED FACTOR-VII LEVELS IN PATIENTS WITH ANGIOGRAPHICALLY CONFIRMED CORONARY-ARTERY DISEASE
Authors: EICHNER JE MOORE WE SCHECHTER E REYNOLDS DW MORRISSEY JH COMP PC
Citation: Je. Eichner et al., ACTIVATED FACTOR-VII LEVELS IN PATIENTS WITH ANGIOGRAPHICALLY CONFIRMED CORONARY-ARTERY DISEASE, The American journal of cardiology, 80(2), 1997, pp. 217-219
MONITORING LOW-DOSE WARFARIN THERAPY BY A CENTRAL LABORATORY AND IMPLICATIONS FOR CLINICAL-TRIALS AND PATIENT-CARE
Authors: RASKOB GE DURICA SS OWEN WL COMP PC
Citation: Ge. Raskob et al., MONITORING LOW-DOSE WARFARIN THERAPY BY A CENTRAL LABORATORY AND IMPLICATIONS FOR CLINICAL-TRIALS AND PATIENT-CARE, The American journal of cardiology, 78(9), 1996, pp. 1074-1076
FIBRINOGEN LEVELS IN WOMEN HAVING CORONARY ANGIOGRAPHY
Authors: EICHNER JE MOORE WE MCKEE PA SCHECHTER E REYNOLDS DW QI H COMP PC
Citation: Je. Eichner et al., FIBRINOGEN LEVELS IN WOMEN HAVING CORONARY ANGIOGRAPHY, The American journal of cardiology, 78(1), 1996, pp. 15-18
PRELIMINARY DATA FROM A FIELD TRIAL OF THE PFA-100(TM) SYSTEM
Authors: MAMMEN EF ALSHAMEERI RS COMP PC
Citation: Ef. Mammen et al., PRELIMINARY DATA FROM A FIELD TRIAL OF THE PFA-100(TM) SYSTEM, Seminars in thrombosis and hemostasis, 21, 1995, pp. 113-121
ON THE ROLE OF PHOSPHATIDYLETHANOLAMINE IN THE INHIBITION OF ACTIVATED PROTEIN-C ACTIVITY BY ANTIPHOSPHOLIPID ANTIBODIES
Authors: SMIRNOV MD TRIPLETT DT COMP PC ESMON NL ESMON CT
Citation: Md. Smirnov et al., ON THE ROLE OF PHOSPHATIDYLETHANOLAMINE IN THE INHIBITION OF ACTIVATED PROTEIN-C ACTIVITY BY ANTIPHOSPHOLIPID ANTIBODIES, The Journal of clinical investigation, 95(1), 1995, pp. 309-316
SELECTIVE REMOVAL OF PLASMA LOW-DENSITY-LIPOPROTEIN WITH THE HELP SYSTEM - BIWEEKLY VERSUS WEEKLY THERAPY
Authors: LANE DM MCCONATHY WJ LAUGHLIN LO COMP PC VONALBERTINI B BRICKER LA KOZLOVSKIS P LEES RS DORRIER C
Citation: Dm. Lane et al., SELECTIVE REMOVAL OF PLASMA LOW-DENSITY-LIPOPROTEIN WITH THE HELP SYSTEM - BIWEEKLY VERSUS WEEKLY THERAPY, Atherosclerosis, 114(2), 1995, pp. 203-211
EFFECT OF TREATMENT WITH LOW-DOSE WARFARIN-ASPIRIN ON ACTIVATED FACTOR-VII
Authors: RASKOB GE DURICA SS MORRISSEY JH OWEN WL COMP PC
Citation: Ge. Raskob et al., EFFECT OF TREATMENT WITH LOW-DOSE WARFARIN-ASPIRIN ON ACTIVATED FACTOR-VII, Blood, 85(11), 1995, pp. 3034-3039
ACTIVATED FACTOR-VII - POTENTIAL FOR INDEPENDENT PREDICTION OF THROMBOTIC RISK
Authors: EISENBRAUN AJ MORRISSEY JH COMP PC GILCHER RO KOLODZIEJ MA
Citation: Aj. Eisenbraun et al., ACTIVATED FACTOR-VII - POTENTIAL FOR INDEPENDENT PREDICTION OF THROMBOTIC RISK, Clinical research, 42(2), 1994, pp. 10000185-10000185
THROMBOMODULIN ANTIBODIES ARE FOUND IN PATIENTS WITH LUPUS ANTICOAGULANT AND UNEXPLAINED THROMBOSIS
Authors: CARSON CW COMP PC ESMON NL REZAIE AR ESMON CT
Citation: Cw. Carson et al., THROMBOMODULIN ANTIBODIES ARE FOUND IN PATIENTS WITH LUPUS ANTICOAGULANT AND UNEXPLAINED THROMBOSIS, Circulation, 90(4), 1994, pp. 132-132
THROMBOMODULIN ANTIBODIES ARE FOUND IN PATIENTS WITH LUPUS ANTICOAGULANT AND UNEXPLAINED THROMBOSIS
Authors: CARSON CW COMP PC ESMON NL REZAIE AR ESMON CT
Citation: Cw. Carson et al., THROMBOMODULIN ANTIBODIES ARE FOUND IN PATIENTS WITH LUPUS ANTICOAGULANT AND UNEXPLAINED THROMBOSIS, Circulation, 90(4), 1994, pp. 132-132
EFFECT OF LOW-DOSE WARFARIN-ASPIRIN ON ACTIVATED FACTOR-VII
Authors: RASKOB GE DURICA SS MORRISSEY JH OWEN WL COMP PC
Citation: Ge. Raskob et al., EFFECT OF LOW-DOSE WARFARIN-ASPIRIN ON ACTIVATED FACTOR-VII, Circulation, 90(4), 1994, pp. 569-569
EFFECT OF LOW-DOSE WARFARIN-ASPIRIN ON ACTIVATED FACTOR-VII
Authors: RASKOB GE DURICA SS MORRISSEY JH OWEN WL COMP PC
Citation: Ge. Raskob et al., EFFECT OF LOW-DOSE WARFARIN-ASPIRIN ON ACTIVATED FACTOR-VII, Circulation, 90(4), 1994, pp. 569-569
SAFETY AND ANTICOAGULATION EFFECT OF A LOW-DOSE COMBINATION OF WARFARIN AND ASPIRIN IN CLINICALLY STABLE CORONARY-ARTERY DISEASE
Authors: GOODMAN SG LANGER A DURICA SS RASKOB GE COMP PC GRAY RJ HALL JH KELLEY RP HUA TA LEE RJ FUSTER V
Citation: Sg. Goodman et al., SAFETY AND ANTICOAGULATION EFFECT OF A LOW-DOSE COMBINATION OF WARFARIN AND ASPIRIN IN CLINICALLY STABLE CORONARY-ARTERY DISEASE, The American journal of cardiology, 74(7), 1994, pp. 657-661
PRO-HEMOSTATIC EFFECTS OF INTERLEUKIN-6 - AUGMENTATION OF PLATELET ACTIVATION AND PLASMA VON-WILLEBRAND-FACTOR AND REDUCTION IN FREE PROTEIN-S IN DOGS
Authors: BURSTEIN SA PENG JP DALE GL HAMILTON KK COMP PC GEORGE JN
Citation: Sa. Burstein et al., PRO-HEMOSTATIC EFFECTS OF INTERLEUKIN-6 - AUGMENTATION OF PLATELET ACTIVATION AND PLASMA VON-WILLEBRAND-FACTOR AND REDUCTION IN FREE PROTEIN-S IN DOGS, Thrombosis and haemostasis, 69(6), 1993, pp. 749-749
SAFETY AND EFFICACY OF A LOW-DOSE COMBINATION OF COUMADIN AND ASPIRIN
Authors: LANGER A GOODMAN SG COMP PC RASKOB G DURICA S GRAY RJ HALL J KELLEY RP HUA IA LEE RJ
Citation: A. Langer et al., SAFETY AND EFFICACY OF A LOW-DOSE COMBINATION OF COUMADIN AND ASPIRIN, Circulation, 88(4), 1993, pp. 493-493
CONTRACEPTIVE CHOICES IN WOMEN WITH COAGULATION DISORDERS
Authors: COMP PC ZACUR HA
Citation: Pc. Comp et Ha. Zacur, CONTRACEPTIVE CHOICES IN WOMEN WITH COAGULATION DISORDERS, American journal of obstetrics and gynecology, 168(6), 1993, pp. 1990-1993
DOSE-RELATED EFFICACY AND BLEEDING COMPLICATIONS OF DOUBLE-CHAIN TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION
Authors: TURI ZG GOLDBERG S LITTLEJOHN JK VANDERARK C SHADOFF N KARLSBERG R WILLIAMS J BUTMAN S STADIUS ML WISE K BUCHBINDER M GENTON E LASKEY WK DEMARIA A WHITE C SHEEHAN F COMP PC WYNNE J BATSONFOWLER G EDWARDS S
Citation: Zg. Turi et al., DOSE-RELATED EFFICACY AND BLEEDING COMPLICATIONS OF DOUBLE-CHAIN TISSUE PLASMINOGEN-ACTIVATOR IN ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 71(12), 1993, pp. 1009-1014
NATURAL ANTICOAGULANTS IN SMOKERS - REPLY
Authors: COMP PC
Citation: Pc. Comp, NATURAL ANTICOAGULANTS IN SMOKERS - REPLY, The American heart journal, 125(6), 1993, pp. 1806-1807
Risultati: 1-23 |